- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07652775
rTMS Combined With Aerobic Exercise for Older Adults With Mild Cognitive Impairment and Comorbid Depression
Effects of Repetitive Transcranial Magnetic Stimulation Combined With Aerobic Exercise on Cognitive Function, Psychological Health, and Walking Performance in Older Adults With Mild Cognitive Impairment and Comorbid Depression: A Randomized Controlled Trial
연구 개요
상태
상세 설명
Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia and is frequently accompanied by depressive symptoms. Older adults with MCI and comorbid depression are at increased risk of cognitive decline, functional impairment, reduced quality of life, and progression to dementia. Therefore, effective non-pharmacological interventions targeting both cognitive and mental health outcomes are needed.
This study aims to investigate the effects of rTMS alone and rTMS combined with aerobic exercise on cognitive and mental health outcomes in older adults with MCI and comorbid depression. A randomized controlled trial design will be employed. Forty-five eligible participants who provide written informed consent will be randomly assigned to one of three groups: (1) rTMS alone, (2) rTMS combined with stationary cycling exercise, and (3) sham rTMS combined with stationary cycling exercise.
All participants will receive 20 intervention sessions over a 5-week intervention period (4 sessions per week). Intervention sessions will be conducted on Monday, Tuesday, Thursday, and Friday. Participants in the rTMS-alone group will receive a 5-minute rTMS session only. Participants in the rTMS combined with stationary cycling exercise group and the sham rTMS combined with stationary cycling exercise group will receive either active or sham rTMS for 5 minutes, followed by 30 minutes of stationary cycling exercise.
The stimulation target will be the left dorsolateral prefrontal cortex (DLPFC). For sham stimulation, a figure-of-eight coil will be positioned with one wing angled at 90 degrees relative to the scalp and maintained approximately 3 cm from the scalp surface to mimic the sensory experience of active stimulation while minimizing effective cortical stimulation.
Outcome assessments will be conducted at baseline, immediately after completion of the 5-week intervention period, and at a 1-month follow-up. Outcome measures will include cognitive function, depressive symptoms, sleep quality, life satisfaction, self-efficacy, and gait performance. Each assessment session is expected to require approximately 45 minutes.
The findings may provide evidence supporting the application of combined neuromodulation and aerobic exercise interventions for improving cognitive and mental health outcomes in older adults with MCI and comorbid depression.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Ya-Chu Chan, MS Candidate
- 전화번호: +886-983-559-807
- 이메일: aya45285@gmail.com
연구 장소
-
-
Taipei City
-
Taipei, Taipei City, 대만, 112
- 모병
- Cheng Hsin General Hospital
-
연락하다:
- Ya-Chu Chan, MS Candidate
- 전화번호: +886-983-559-807
- 이메일: aya45285@gmail.com
-
연락하다:
- Kai-Chen Chan, MD
- 전화번호: +886-983-559-807
- 이메일: aya45285@gmail.com
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Aged 65 to 90 years.
- Diagnosed with mild cognitive impairment (MCI) according to established clinical criteria.
- Presence of depressive symptoms as determined by clinical assessment and Beck Depression Inventory-II (BDI-II).
- Able to communicate and follow study instructions.
- Able to ambulate independently with or without an assistive device.
- Able to provide written informed consent.
Exclusion Criteria:
- Diagnosis of dementia.
- History of epilepsy or seizure disorder.
- Presence of metallic implants, pacemakers, cochlear implants, or other contraindications to transcranial magnetic stimulation.
- Major neurological disorders, including stroke, Parkinson's disease, traumatic brain injury, or other neurodegenerative diseases.
- Severe psychiatric disorders other than depression.
- Severe cardiovascular, musculoskeletal, or medical conditions that preclude participation in aerobic exercise.
- Severe visual or hearing impairments that interfere with cognitive assessment.
- Current participation in another intervention study.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: rTMS Alone
Participants receive active repetitive transcranial magnetic stimulation (rTMS) targeting the left dorsolateral prefrontal cortex (DLPFC).
Stimulation sessions are conducted 4 times per week for 5 weeks (20 sessions total).
|
Active repetitive transcranial magnetic stimulation (rTMS) is delivered over the left dorsolateral prefrontal cortex (DLPFC) using a figure-of-eight coil.
Participants receive stimulation sessions 4 times per week for 5 weeks (20 sessions total).
다른 이름들:
|
|
실험적: rTMS Combined With Aerobic Exercise
Participants receive active repetitive transcranial magnetic stimulation (rTMS) targeting the left dorsolateral prefrontal cortex (DLPFC), immediately followed by 30 minutes of moderate-intensity stationary cycling exercise.
Sessions are conducted 4 times per week for 5 weeks (20 sessions total).
|
Active repetitive transcranial magnetic stimulation (rTMS) is delivered over the left dorsolateral prefrontal cortex (DLPFC) using a figure-of-eight coil.
Participants receive stimulation sessions 4 times per week for 5 weeks (20 sessions total).
다른 이름들:
Participants perform 30 minutes of moderate-intensity stationary cycling exercise immediately following rTMS or sham rTMS sessions.
Exercise sessions are conducted 4 times per week for 5 weeks (20 sessions total).
|
|
실험적: Sham rTMS Combined With Aerobic Exercise
Participants receive sham repetitive transcranial magnetic stimulation (rTMS) targeting the left dorsolateral prefrontal cortex (DLPFC), immediately followed by 30 minutes of moderate-intensity stationary cycling exercise.
Sham stimulation is delivered using a figure-of-eight coil positioned at a 90-degree angle relative to the scalp and approximately 3 cm from the scalp surface to mimic the sensory and auditory experience of active stimulation without inducing effective cortical activation.
Sessions are conducted 4 times per week for 5 weeks (20 sessions total).
|
Participants perform 30 minutes of moderate-intensity stationary cycling exercise immediately following rTMS or sham rTMS sessions.
Exercise sessions are conducted 4 times per week for 5 weeks (20 sessions total).
Sham stimulation is delivered using a figure-of-eight coil positioned at a 90-degree angle relative to the scalp and approximately 3 cm away from the scalp surface to mimic the sensory and auditory experience of active stimulation without producing effective cortical activation.
Participants receive sham stimulation sessions 4 times per week for 5 weeks (20 sessions total).
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Montreal Cognitive Assessment (MoCA)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in global cognitive function measured using the Montreal Cognitive Assessment (MoCA).
Higher scores indicate better cognitive performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Geriatric Depression Scale-15 (GDS-15)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in depressive symptoms measured using the Geriatric Depression Scale-15 (GDS-15).
Higher scores indicate greater depressive symptom severity.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Pittsburgh Sleep Quality Index (PSQI)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI).
Lower scores indicate better sleep quality.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Trail Making Test Part A (TMT-A)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in attention and processing speed measured using the Trail Making Test Part A. Shorter completion times indicate better performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Trail Making Test Part B (TMT-B)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Shorter completion times indicate better executive functioning and cognitive flexibility.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
California Verbal Learning Test-Short Form (CVLT-SF)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in verbal learning and memory measured using the California Verbal Learning Test-Short Form (CVLT-SF).
Higher scores indicate better verbal learning and memory performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Stroop Color-Word Test
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in executive function, selective attention, and inhibitory control measured using the Stroop Color-Word Test (SCWT).
Performance is assessed as the number of correct responses completed within 1 minute.
Higher scores indicate better executive function, selective attention, and inhibitory control.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Digit Span Forward Test
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in attention span and immediate verbal memory measured using the Digit Span Forward Test.
Higher scores indicate better attention and short-term memory performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Digit Span Backward Test
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in working memory and executive function measured using the Digit Span Backward Test.
Higher scores indicate better working memory performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Beck Depression Inventory-II (BDI-II)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Higher scores indicate greater depressive symptom severity.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
EuroQol Five-Dimension Five-Level Questionnaire Index Score (EQ-5D-5L Index)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in health-related quality of life measured using the EuroQol Five-Dimension Five-Level Questionnaire Index Score (EQ-5D-5L Index).
Higher scores indicate better health-related quality of life.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
World Health Organization Quality of Life-BREF (WHOQOL-BREF)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in quality of life measured using the World Health Organization Quality of Life-BREF (WHOQOL-BREF).
Higher scores indicate better quality of life.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Chinese Aging Well Profile (CAWP)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in subjective well-being measured using the Chinese Aging Well Profile (CAWP).
Higher scores indicate better subjective well-being.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Timed Up and Go Test (TUG)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in functional mobility measured using the Timed Up and Go Test (TUG).
Participants are instructed to stand up from a chair, walk 3 meters, turn around, walk back, and sit down.
Shorter completion times indicate better functional mobility and balance performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
EuroQol Visual Analogue Scale Score (EQ-VAS)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in self-rated health status measured using the EuroQol Visual Analogue Scale (EQ-VAS).
Higher scores indicate better perceived health status.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Dual-task gait speed (m/s)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in dual-task gait speed measured in meters per second (m/s).
Higher values indicate better gait performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Dual-task cadence (steps/min)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in dual-task cadence measured in steps per minute.
Higher values indicate better gait performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Dual-task stride length (m)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Changes in dual-task stride length measured in meters.
Higher values indicate better gait performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Dual-task cost (%)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Percentage change in gait performance during dual-task walking relative to single-task walking.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Single-task gait speed (m/s)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Walking speed during single-task walking, measured in meters per second.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Single-task cadence (steps/min)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Higher values indicate better gait performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
|
Single-task stride length (m)
기간: Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
Higher values indicate better gait performance.
|
Baseline through 1-month follow-up (assessed at baseline, immediately after the 5-week intervention, and 1 month after intervention completion)
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Kai-Chen Wang, MD, Cheng-Hsin General Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- (1184)114-42
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Repetitive Transcranial Magnetic Stimulation에 대한 임상 시험
-
Hospital Center Guillaume Régnier모병
-
Stanford UniversityNYU Langone Health; Wills Eye; Otto-von-Guericke University Magdeburg모집하지 않고 적극적으로
-
The Mind Research NetworkUniversity of New Mexico모집하지 않고 적극적으로